FDA Investigator Lori J Silverstein

Lori J Silverstein has inspections in 7 countries as of 29 Sep 2023. Lori J Silverstein has collaborated with a combinined 5084 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
234
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Israel, India, United Kingdom of Great Britain and Northern Ireland, France, Ireland, Germany
Co-Investigator(s):
A Williams, Abby M Miller, Adam R Cooke, Adam S Freeman, Alan D Grupe, Alexander M Kay, Alexandra B Pitkin, Alexandria L Capuano, Alicia A Borg Borm, Amy R Glynn, Anderson, Andrew K Haack, PhD, Andrew R Wasko, Angela Shepas, Anita Narula, PhD, Anthony E Keller, RPh, Arie C Menachem, Ashleigh P Barkans, Astrida B Mattson, Barbar J Breithaupt, Barbara Janine Breithaupt, Barbara R Pfrunder, Binh T Nguyen, Bowman, Brenda K Alford, Brenda L Reihing, Brenda L Reiling, Brian P Putz, Bruce R Burrell, Bryce E Mansfield, Burnell M Henry, Bush, Calvin K Cook, Camille Bennett Hoffman, Carl A Anderson, Carr Sharpe, Catherine J Laufmann, Celeta S Coves, Chaoying C Ma, Charles R Bonapace, PhD, Chiaochun J Wang, Christina V Santos, Christine M Parmentier, Christopher R Czajka, Christopher S Genther, Colleen M Jones, Connie P Rezendes, Courtney N Long, Creighton T Tuzon, Ct Viswanathan, PhD, Cynthia L Gorveatt, Da Lin Yao, MD, PhD, Daniel J Lahar, David L Hunsaker, David Y Hernandez, Dawn E Barkans, Deborah A Nebenzahl, Debra D Devlieger, Debra J Fracassa, Denise M Zavagno, Dennis G Kawabata, Devon M Shoop, Dianna D Wardlow Dotter, Dirk L Lincoln, Dolores E Price, Donald B Mckechnie, Douglas J Scott, Dr. Carmelo Rosa, Dr. Guang Gao, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Edward D Harris, Elizabeth A Sheller, Elizabeth S Howell, Ellen N Stewart, Emil P Wang, JD, Erin M Mcdowell, Francis J Eng, Frank Verni, Gary L Zaharek, Gavin T Cua, Gene D Arcy, Gerard Pde Leon, Gloria J Baca, MS, Gordon T Wales, Grace P Santos, Graham N Giesen, Gregson A Joseph, Harmon M Blanch, Harperd, Heika R Bounds, Heika R Tait, Herminio C Francisco, Hoover, Hugh Grimoldby, Hugh M Mcclure, II, Humberto Z Gomez, Ian J Thomson, Ismael Olvera, IV, Ivis Lnegron Torres, Jacob G Lutz, Jacqueline A O'shaughnessy, PhD, James A Lane, James D Hildreth, James E Trabert, James R Fleckenstein, James R Montero, Jane M Kreis, Jane R Donnelly, Jean R Mccurry, Jeanne M Weishaar, Jeannine K Wooten, Jeff M Uriarte, Jeffrey J Leclair, Jeffrey N Gerdes, Jeffrey W Shrifter, DPM, Jenny L Chisem, Jessica L Johnson, Jessie J Deloach, Jinkee Mvila Binayug, Jinkee Mvila Dinayug, Jinnie Kokiatkulkij, Joan T Briones, Jocelyn E Massey, Jocelyn T Ramos, John A Hall, John E Emmert, John W Banks, Jonathan T Little, Jose Alopez Rubet, Judy C Nepsa, Judy Strojny Not In Use, Julia E Chervoni, Julian C Hanson, K Gonzlez, Karen S Anthony, Kari M Johansen, Katherine L Arnold, Kathryn A Krentz, Kay, Kelsey A Hustedt, Kelsey A Volkman, Kenneth O Gee, PhD, Keren Arkin, Kerri E Butler, Kevin Lee, Kevin T Gerrity, Kimberly J Proctor Jones, Kimberly Lewandowski Walker, Kristina M Phelps, Kun C Liu, Kurt M Hafer, Larry K Austin, Lata C Mathew, PhD, Lauren E Swantko, Lawrence Y Lee, PhD, Leonard H Lavi, Leya A Grosch, Lilly O Barton, Linda Linh T Nguyen, Linda S Leja, Lisa A Bowden, Lisa K Capron, Lon A Cummings, Lorna F Jones, LT Mark A Chen, MPH, Maan S Abduldayem, Madushini Dharmasena, PhD, Makini Cobourne Duval, PhD, Margaret M Annes, Margo C Jones, Margo Cl Jones, Maria Pkelly Doggett, MBA, Marie K Kinkade, Marijo B Kambere, PhD, Mark E Chan, Mark E Imsland, Mark E Moen, Mark S Crippen, Mark W Babbitt, Mary E Farbman, PhD, Mary R Hole, Maryam Tabatabaie, Matthew D Feist, Maura Rooney, Maxyne T Lam, Michael A Charles, Michael A Taylor, Michael F Skelly, PhD, Michael J Donovan, Mihaly S Ligmond, Mikel T Wright, Minh D Phan, Mohsen Rajabi Abhari, FDA, Msdap Gonzlezk, Nancy A Saxenian Emmons, Nancy E Byerly, Nancy E Doyle, Neil J Traaen, Nianna C Burns, Nichole A Broadhacker, Norman Wong, Omotunde O Osunsanmi, Patricia Fhughes Troost, Paul F Rader, Paul Kawamoto, Paul L Bellamy, Paul M Kawamoto, Paula A Trost, Paula J Wilkerson, Peter E Baker, Peter Kessler, PhD, Peter R Lenahan, Peter T Regan, Phal K Chhun, Philip E Ake, Phillip M Pontikos, Prabhu P Raju, Randy L Self, Raymond T Oji, Rebecca A Sletner, Rebecca L Stephany, Rebecca T Davis, Richard A Martin, Richard G Runyon, Richard Jay Tucker, RS, Richard Ledwidge (nmi), PhD, Robert D Tollefsen, Robert J Doyle, Robert J Ham, Rocco C Black, Rochelle A Rolnik, Rodney D Combs, Ronald E Gill, Ronald T Weber, Ryan J Borges, S Lori Brown, PhD MPH, Sam H Haidar, PhD, Sandra K Wangen, Sangeeta M Khurana, PhD, Savini, Scott A Nabe, Scott J Matsuda, Scott K Zika, Scott W Fox, Selene T Torres, Sergio Chavez (NMI), Shaquenta Y Perkins, Sharon I Gundersen, Sharon L Shane, Shelagh D Schopen, Shelley H Beausoleil, Sheri N Rohlf, Sherri N Rohlf, MD, Sonya L Karsik, Stanley B Eugene, BS, BME, State Agency, Stephanie A Slater, MS, Stephen R Souza, Steven E Kane, Steven M Weinman, Sunitha K Rajaram, PhD, Susant Hadman, Suzie L Kent, Tara A Marshall, Tara M Pianko, Teresa Jimenez, Terri L Dodds, Thao T Kwan, Thea C Grome, Thomas C Mclean, CFS, Thomas J Arista, Timothy C Grome, Timothy S Williamson, Tuan D Tran, V Teres Speer, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Vicky L Cruz, Victor A Meo, Victor H Loo, Virgilio F Pacio, CSO, William J Foust, William J Leonard, Willis L Hicks, Xiaojun Yan, Yvonne C Wilkes, Zachary A Bogorad

Lori J Silverstein's Documents

Publish Date Document Type Title
July, 2003 FDA 483 Sybronendo, Div of Ormco Corp - Form 483, 2003-07-24
May, 2009 EIR BIOTRONIK Inc - EIR, 2009-05-20
August, 2003 FDA 483 Philips North America LLC - Form 483, 2003-08-19
April, 2004 EIR Altasciences Preclinical Seattle, LLC - EIR, 2004-04-26
December, 2004 FDA 483 Pascal Company, Inc. - Form 483, 2004-12-20
January, 2015 FDA 483 Padagis Israel Pharmaceuticals Ltd - Form 483, 2015-01-22
July, 2003 EIR Sybronendo, Div of Ormco Corp - EIR, 2003-07-24
January, 2012 FDA 483 Sagemax Bioceramics, Inc. - Form 483, 2012-01-24
July, 2012 FDA 483 Vidco, Inc. - Form 483, 2012-07-02
April, 2015 FDA 483 Cortex Manufacturing Inc. - Form 483, 2015-04-01
August, 2003 FDA 483 Response Philips North America LLC - Form 483R, 2003-08-22
April, 2012 FDA 483 Spacelabs Healthcare Inc - Form 483, 2012-04-18
September, 2005 EIR BIOTRONIK Inc - EIR, 2005-09-13
November, 2003 EIR Mark Reisman M.D. - EIR, 2003-11-25
August, 2003 EIR Philips North America LLC - EIR, 2003-08-19
August, 2005 FDA 483 Response Neuro-Fitness LLC - Form 483R, 2006-03-01
December, 2009 FDA 483 Tricol Biomedical, Inc. - Form 483, 2009-12-11
May, 2008 FDA 483 Response Spacelabs Healthcare Inc - Form 483R, 2008-05-30
August, 2010 FDA 483 Philips North America LLC - Form 483, 2010-08-09
August, 2010 EIR Philips North America LLC - EIR, 2012-08-29
April, 2003 FDA 483 Fine Howard - Form 483, 2003-04-04
May, 2008 FDA 483 Spacelabs Healthcare Inc - Form 483, 2008-05-09
December, 2004 FDA 483 Response Pascal Company, Inc. - Form 483R, 2004-12-17
August, 2014 FDA 483 Sagemax Bioceramics, Inc. - Form 483, 2014-08-18
April, 2003 EIR Fine Howard - EIR, 2003-04-04
April, 2003 FDA 483 Response Fine Howard - Form 483R, 2003-04-18
October, 2003 EIR Spentech, Inc. - EIR, 2003-10-29
July, 2015 FDA 483 Prodimed SAS - Form 483, 2015-07-02
October, 2003 FDA 483 Spentech, Inc. - Form 483, 2003-10-29
March, 2012 EIR Philips Medical Systems North America Inc. - EIR, 2012-03-19
May, 2005 EIR Mark Reisman M.D. - EIR, 2005-05-13
February, 2005 FDA 483 Catch Incorporated - Form 483, 2005-03-18
February, 2005 EIR Catch Incorporated - EIR, 2005-02-24
September, 2003 EIR Fresenius Kabi, LLC - EIR, 2003-09-30
November, 2003 FDA 483 Mark Reisman M.D. - Form 483, 2003-11-25
May, 2005 FDA 483 Mark Reisman M.D. - Form 483, 2005-05-13
June, 2005 FDA 483 ElderTech Solutions, LLC - Form 483, 2005-06-13
November, 2003 EIR Institutional Review Board of Swedish Health Services - EIR, 2003-11-25
June, 2015 FDA 483 Sagemax Bioceramics, Inc. - Form 483, 2015-06-03
June, 2009 FDA 483 Lacrimedics Inc - Form 483, 2009-06-11
March, 2012 FDA 483 Philips Medical Systems North America Inc. - Form 483, 2012-03-19
September, 2014 FDA 483 AutoGenomics, Inc. - Form 483, 2014-09-26

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more